Using microRNA profiles to predict and evaluate hepatic carcinogenic potential

Toxicology Letters

Volumn 228, Issue 2, 2014, Pages 127-132

  Gooderham, N J ^a   Koufaris, C ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b CYPRUS INSTITUTE OF NEUROLOGY AND GENETICS   (Cyprus)

Author keywords

Carcinogen; Epigenetic; Liver; MicroRNA

Indexed keywords

BENZO[A]PYRENE; CARCINOGEN; DIOXIN; MICRORNA; MICRORNA 200; MICRORNA 200A; MICRORNA 200B; MICRORNA 200C; MICRORNA 34A; N (2 FLUORENYL)ACETAMIDE; PHENOBARBITAL; TRANSCRIPTION FACTOR ZEB1; TRANSCRIPTOME; XENOBIOTIC AGENT;

CARCINOGENICITY; CELL POPULATION; EPITHELIAL MESENCHYMAL TRANSITION; EXPOSURE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIVER CARCINOGENESIS; LIVER CELL; LIVER TOXICITY; MICROARRAY ANALYSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRECANCER; PRIORITY JOURNAL; REVIEW; RNA FINGERPRINTING; RNA PROCESSING; RNA SEQUENCE; TOXICITY TESTING; UPREGULATION;

CARCINOGEN; EPIGENETIC; LIVER; MICRORNA;

ANIMALS; CARCINOGENICITY TESTS; CARCINOGENS; GENE EXPRESSION PROFILING; HUMANS; LIVER NEOPLASMS; MICRORNAS; PREDICTIVE VALUE OF TESTS; TOXICOGENETICS;

EID: 84901228229     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2014.04.015     Document Type: Review

References (41)

1. Ament Z., Waterman C.L., West J.A., Waterline C., Currie R.A., Wright J., Griffin J.L. A metabolomics investigation of non-genotoxic carcinogenicity in the rat. J. Proteome Res. 2013, 6(12):5775-5790.
2. Bala S., Petrasek J., Mundkur S., Catalano D., Levin I., Ward J., Alao H., Kodys K., Szabo G. Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases. Hepatology 2012, 56(5):1946-1957.
3. Blomme E.A., Yang Y., Waring J.F. Use of toxicogenomics to understand mechanisms of drug-induced hepatotoxicity during drug discovery and development. Toxicol. Lett. 2009, 186(1):22-31.
4. Boobis A.R., Cohen S.M., Doerrer N.G., Galloway S.M., Haley P.J., Hard G.C., Hess F.G., Macdonald J.S., Thibault S., Wolf D.C., Wright J. A data-based assessment of alternative strategies for identification of potential human cancer hazards. Toxicol. Pathol. 2009, 37(6):714-732.
5. Brabletz S., Brabletz T. The ZEB/miR-200 feedback loop - a motor of cellular plasticity in development and cancer?. EMBO Rep. 2010, 11(9):670-677.
6. Chen T., Mally A., Ozden S., Chipman J.K. Low doses of the carcinogen furan alter cell cycle and apoptosis gene expression in rat liver independent of DNA methylation. Environ. Health Persp. 2010, 118(11):1597-1602.
7. Chen T., Li Z., Yan J., Yang X., Salminen W. MicroRNA expression profiles distinguish the carcinogenic effects of riddelliine in rat liver. Mutagenesis 2012, 27(1):59-66.
8. Ding W., Dang H., You H., Steinway S., Takahashi Y., Wang H.G., Liao J., Stiles B., Albert R., Rountree C.B. miR-200b restoration and DNA methyltransferase inhibitor block lung metastasis of mesenchymal-phenotype hepatocellular carcinoma. Oncogenesis 2012, 11:e15.
9. Fielden M.R., Adai A., Dunn R.T., Olaharski A., Searfoss G., Sina J., Aubrecht J., Boitier E., Nioi P., Auerbach S., Jacobson-Kram D., Raghavan N., Yang Y., Kincaid A., Sherlock J., Chen S.J., Car B. Development and evaluation of a genomic signature for the prediction and mechanistic assessment of nongenotoxic hepatocarcinogens in the rat. Toxicol. Sci. 2011, 124(1):54-74. Predictive Safety Testing Consortium, Carcinogenicity Working Group.
10. Hardisty J.F., Brix A.E. Comparative hepatic toxicity: prechronic/chronic liver toxicity in rodents. Toxicol. Pathol. 2005, 33(1):35-40.
11. Hou J., Lin L., Zhou W., Wang Z., Ding G., Dong Q., Qin L., Wu X., Zheng Y., Yang Y., Tian W., Zhang Q., Wang C., Zhang Q., Zhuang S.M., Zheng L., Liang A., Tao W., Cao X. Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 15 2011, 19(2):232-243.
12. Kirsch-Volders M., Plas G., Elhajouji A., Lukamowicz M., Gonzalez L., Vande Loock K., Decordier I. The in vitro MN assay in 2011: origin and fate, biological significance, protocols, high throughput methodologies and toxicological relevance. Arch. Toxicol. 2011, 85(8):873-899.
13. Kosaka N., Yoshioka Y., Hagiwara K., Tominaga N., Katsuda T., Ochiya T. Trash or treasure: extracellular microRNAs and cell-to-cell communication. Front. Genet. 2013, 5(4):173.
14. Kota J., Chivukula R.R., O'Donnell K.A., Wentzel E.A., Montgomery C.L., Hwang H.W., Chang T.C., Vivekanandan P., Torbenson M., Clark K.R., Mendell J.R., Mendell J.T. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009, 12(137(6)):1005-1017.
15. Koturbash I., Melnyk S., James S.J., Beland F.A., Pogribny I.P. Role of epigenetic and miR-22 and miR-29b alterations in the downregulation of Mat1a and Mthfr genes in early preneoplastic livers in rats induced by 2-acetylaminofluorene. Mol. Carcinogen. 2013, 52(4):318-327.
16. Koufaris C., Wright J., Osborne M., Currie R.A., Gooderham N.J. Time and dose-dependent effects of phenobarbital on the rat liver miRNAome. Toxicology 15 2013, 314(2-3):247-253.
17. Koufaris C., Gooderham N.J. Are differences in microRNA regulation implicated in species-dependent response to toxicological exposures?. Toxicol. Sci. 2013, 131(2):337-342.
18. Koufaris C., Wright J., Currie R.A., Gooderham N.J. Hepatic microRNA profiles offer predictive and mechanistic insights after exposure to genotoxic and epigenetic hepatocarcinogens. Toxicol. Sci. 2012, 128(August (2)):532-543.
19. Lempiäinen H., Couttet P., Bolognani F., Müller A., Dubost V., Luisier R., Del Rio Espinola A., Vitry V., Unterberger E.B., Thomson J.P., Treindl F., Metzger U., Wrzodek C., Hahne F., Zollinger T., Brasa S., Kalteis M., Marcellin M., Giudicelli F., Braeuning A., Morawiec L., Zamurovic N., Längle U., Scheer N., Schübeler D., Goodman J., Chibout S.D., Marlowe J., Theil D., Heard D.J., Grenet O., Zell A., Templin M.F., Meehan R.R., Wolf R.C., Elcombe C.R., Schwarz M., Moulin P., Terranova R., Moggs J.G. Identification of Dlk1-Dio3 imprinted gene cluster noncoding RNAs as novel candidate biomarkers for liver tumor promotion. Toxicol. Sci. 2013, 131(2):375-386.
20. Li Z., Branham W.S., Dial S.L., Wang Y., Guo L., Shi L., Chen T. Genomic analysis of microRNA time-course expression in liver of mice treated with genotoxiccarcinogen N-ethyl-N-nitrosourea. BMC Genomics 2010, 28(11):609.
21. Li Z., Fuscoe J.C., Chen T. MicroRNAs and their predicted target messenger RNAs are deregulated by exposure to a carcinogenic dose of comfrey in rat liver. Environ. Mol. Mutagen. 2011, 52(6):469-478.
22. Malik A.I., Williams A., Lemieux C.L., White P.A., Yauk C.L. Hepatic mRNA, microRNA, and miR-34a-target responses in mice after 28 days exposure to doses of benzo(a)pyrene that elicit DNA damage and mutation. Environ. Mol. Mutagen. 2012, 53(1):10-21.
23. Mendell J.T., Olson E.N. MicroRNAs in stress signaling and human disease. Cell 2012, 16(148(6)):1172-1187.
24. Moffat I.D., Boutros P.C., Celius T., Lindén J., Pohjanvirta R., Okey A.B. microRNAs in adult rodent liver are refractory to dioxin treatment. Toxicol. Sci. 2007, 99(2):470-487.
25. Pogribny I.P., Tryndyak V.P., Boyko A., Rodriguez-Juarez R., Beland F.A., Kovalchuk O. Induction of microRNAome deregulation in rat liver by long-term tamoxifen exposure. Mutat. Res. 2007, 1(619 (1-2)):30-37.
26. Pogribny I.P., Muskhelishvili L., Tryndyak V.P., Beland F.A. The tumor-promoting activity of 2-acetylaminofluorene is associated with disruption of the p53 signaling pathway and the balance between apoptosis and cell proliferation. Toxicol. Appl. Pharmacol. 2009, 15(235 (3)):305-311.
27. Ross J.A., Blackman C.F., Thai S.F., Li Z., Kohan M., Jones C.P., Chen T. A potential microRNA signature for tumorigenic conazoles in mouse liver. Mol. Carcinogen. 2010, 49(4):320-323.
28. Sekine S., Ogawa R., Ito R., Hiraoka N., McManus M.T., Kanai Y., Hebrok M. Disruption of Dicer1 induces dysregulated fetal gene expression and promotes hepatocarcinogenesis. Gastroenterology 2009, 136(7(2304-2315)):e1-e4.
29. Shah Y.M., Morimura K., Yang Q., Tanabe T., Takagi M., Gonzalez F.J. Peroxisome proliferator-activated receptor alpha regulates a microRNA-mediated signaling cascade responsible for hepatocellular proliferation. Mol. Cell. Biol. 2007, 27(12):4238-4247.
30. Sukata T., Sumida K., Kushida M., Ogata K., Miyata K., Yabushita S., Uwagawa S. Circulating microRNAs, possible indicators of progress of rat hepatocarcinogenesis from early stages. Toxicol. Lett. 2011, 15(200(1-2)):46-52.
31. Tarasov V., Jung P., Verdoodt B., Lodygin D., Epanchintsev A., Menssen A., Meister G., Hermeking H. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 2007, 1(6 (13)):1586-1593.
32. Thomson J.P., Hunter J.M., Lempiäinen H., Müller A., Terranova R., Moggs J.G., Meehan R.R. Dynamic changes in 5-hydroxymethylation signatures underpin early and late events in drug exposed liver. Nucleic Acids Res. 2013, 41(June (11)):5639-5654.
33. Tomimaru Y., Eguchi H., Nagano H., Wada H., Kobayashi S., Marubashi S., Tanemura M., Tomokuni A., Takemasa I., Umeshita K., Kanto T., Doki Y., Mori M. Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma. J. Hepatol. 2012, 56(1):167-175.
34. Valverde M., Rojas E. Environmental and occupational biomonitoring using the Comet assay. Mutat. Res. 2009, 681(1):93-109.
35. Wu X., Song Y. Preferential regulation of miRNA targets by environmental chemicals in the human genome. BMC Genomics 2011, 18(12):244.
36. Xu L., Qin W., Zhang H., Wang Y., Dou H., Wu D., Ding Y., Yang L., Wang Y. Alterations in microRNA expression linked to microcystin-LR-induced tumorigenicity in human WRL-68 cells. Mutat. Res. 2012, 18(743 (1-2)):75-82.
37. Yang X., Greenhaw J., Shi Q., Su Z., Qian F., Davis K., Mendrick D.L., Salminen W.F. Identification of urinary microRNA profiles in rats that may diagnose hepatotoxicity. Toxicol. Sci. 2012, 125(2):335-344.
38. Yauk C.L., Jackson K., Malowany M., Williams A. Lack of change in microRNA expression in adult mouse liver following treatment with benzo(a)pyrene despite robust mRNA transcriptional response. Mutat. Res. 2011, 17(722(2)):131-139.
39. Yokoi T., Nakajima M. Toxicological implications of modulation of gene expression by microRNAs. Toxicol. Sci. 2011, 123(1):1-14.
40. Yoshioka W., Higashiyama W., Tohyama C. Involvement of microRNAs in dioxin-induced liver damage in the mouse. Toxicol. Sci. 2011, 122(2):457-465.
41. Zhao Y., Xie P., Fan H. Genomic profiling of microRNAs and proteomics reveals an early molecular alteration associated with tumorigenesis induced by MC-LR in mice. Environ. Sci. Technol. 2012, 3(46(1)):34-41.